Edition:
India

Australian Pharmaceutical Industries Ltd (API.AX)

API.AX on Australia Stock Exchange

1.29AUD
24 May 2019
Change (% chg)

$0.00 (+0.39%)
Prev Close
$1.29
Open
$1.29
Day's High
$1.32
Day's Low
$1.28
Volume
935,634
Avg. Vol
1,402,818
52-wk High
$1.95
52-wk Low
$1.25

Latest Key Developments (Source: Significant Developments)

Australian Pharmaceutical Industries Sees Signing Non-Disclosure Agreement With Sigma Shortly
Wednesday, 23 Jan 2019 

Jan 23 (Reuters) - Australian Pharmaceutical Industries Ltd ::AUSTRALIAN PHARMACEUTICAL INDUSTRIES SAYS SIGMA HEALTHCARE BID "IS THE BEST OPPORTUNITY TO DELIVER SIGNIFICANT BENEFITS TO CONSUMERS, SHAREHOLDERS".AUSTRALIAN PHARMACEUTICAL INDUSTRIES SAYS "CURRENT STATUS IS THAT WE ARE IN CONSTRUCTIVE DIALOGUE WITH SIGMA ABOUT PROGRESSING OUR PROPOSAL".SEES "SIGNING A NON-DISCLOSURE AGREEMENT SHORTLY THAT WILL THEN ALLOW A DUE DILIGENCE PROCESS TO COMMENCE".  Full Article

Australian Pharmaceutical Industries Expects 1H19 EBIT To Reflect 5 Pct Growth On Prior Year
Wednesday, 23 Jan 2019 

Jan 23 (Reuters) - Australian Pharmaceutical Industries Ltd ::EXPECTS 1H19 EBIT TO REFLECT 5 PERCENT GROWTH ON PRIOR YEAR.  Full Article

Australian Pharmaceutical Industries posts ‍FY profit for period attributable to members $52.371 mln
Thursday, 19 Oct 2017 

Oct 19 (Reuters) - Australian Pharmaceutical Industries Ltd :‍FY profit for period attributable to members $52.371 million versus $51.670 million​.FY ‍revenue from ordinary activities $4.06 billion versus $3.84 billion.Declared ‍final dividend of 3.5 cents​.Expects recent trend in consumer sentiment & discretionary spending will not see reversal in current year​‍​.  Full Article

Australian Pharmaceutical Industries says current chair Peter Robinson to retire
Wednesday, 6 Sep 2017 

Sept 6 (Reuters) - Australian Pharmaceutical Industries Ltd :Mark smith has been appointed as a non-executive director and chair-elect.Current chair Peter Robinson to retire in January 2018.  Full Article

Australian Pharmaceutical Industries revises FY profit guidance
Wednesday, 2 Aug 2017 

Aug 2 (Reuters) - Australian Pharmaceutical Industries Ltd ::Now expects full year net profit after tax to be approximately 5% up on FY16.Expects reported net debt to be positive before December 2017."Pharmacy distribution business remains on track to meet expectations for year".  Full Article

Australia's Sigma Healthcare board rejects API takeover bid

Australian pharmacy operator Sigma Healthcare Ltd's board on Wednesday rejected a A$727 million ($514.5 million) takeover bid from Australian Pharmaceutical Industries Ltd (API) , saying it was not in the best interests of shareholders.